1. Home
  2. KNDI vs TIL Comparison

KNDI vs TIL Comparison

Compare KNDI & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kandi Technologies Group Inc

KNDI

Kandi Technologies Group Inc

HOLD

Current Price

$0.63

Market Cap

61.9M

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

N/A

Current Price

$7.69

Market Cap

52.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KNDI
TIL
Founded
2002
2018
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.9M
52.2M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
KNDI
TIL
Price
$0.63
$7.69
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
70.6K
5.9K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.06
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$5.67
52 Week High
$1.40
$33.83

Technical Indicators

Market Signals
Indicator
KNDI
TIL
Relative Strength Index (RSI) 43.71 51.76
Support Level $0.61 $7.43
Resistance Level $0.70 $7.99
Average True Range (ATR) 0.04 0.22
MACD -0.00 0.01
Stochastic Oscillator 46.97 48.21

Price Performance

Historical Comparison
KNDI
TIL

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: